Literature DB >> 7428801

Effect of cimetidine on microsomal drug metabolism in man.

J Puurunen, E Sotaniemi, O Pelkonen.   

Abstract

The effect of cimetidine on human microsomal drug metabolism was studied. In five of six healthy volunteers therapeutic doses of cimetidine prolonged the half-life of antipyrine (range 12-37%; p < 0.05). Its clearance was decreased in five subjects (range 2-18%) and was increased in one subject (15%), the changes not being statistically significant. The volume of distribution increased on average by about 14% (range 9--19%; p < 0.001). Cimetidine in vitro inhibited the hydroxylation of benzo(a)pyrene and coumarin, as well as the O-deethylation of 7-ethoxycoumarin, by homogenised liver biopsies. The in vitro studies suggest that the effect of cimetidine on antipyrine elimination is due to inhibition of microsomal drug metabolism, which may prove an important drug interaction.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7428801     DOI: 10.1007/bf00561588

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Cimetidine interaction with warfarin.

Authors:  D Hetzel; D Birkett; J Miners
Journal:  Lancet       Date:  1979-09-22       Impact factor: 79.321

2.  Cimetidine/diazepam interaction.

Authors:  U Klotz; V J Anttila; T Reimann
Journal:  Lancet       Date:  1979-09-29       Impact factor: 79.321

3.  Cimetidine inhibits microsomal drug metabolism in the rat.

Authors:  J Puurunen; O Pelkonen
Journal:  Eur J Pharmacol       Date:  1979-05-01       Impact factor: 4.432

4.  Comparison of the O-dealkylation of 7-ethoxycoumarin and the hydroxylation of benzo(a)pyrene in human placenta. Effect of cigarette smoking.

Authors:  M Jacobson; W Levin; P J Poppers; A W Wood; A H Conney
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

5.  Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme.

Authors:  D W Nebert; H V Gelboin
Journal:  J Biol Chem       Date:  1968-12-10       Impact factor: 5.157

6.  Genetic expression of aryl hydrocarbon hydroxylase induction. IV. Interaction of various compounds with different forms of cytochrome P-450 and the effect on benzo(a)pyrene metabolism in vitro.

Authors:  F M Goujon; D W Nebert; J E Gielen
Journal:  Mol Pharmacol       Date:  1972-11       Impact factor: 4.436

7.  Cimetidine and oral anticoagulants.

Authors:  A C Flind
Journal:  Lancet       Date:  1978-11-11       Impact factor: 79.321

8.  Cimetidine potentiation of the hypoprothrombinemic effect of warfarin.

Authors:  B A Silver; W R Bell
Journal:  Ann Intern Med       Date:  1979-03       Impact factor: 25.391

9.  Rapid gas-liquid chromatographic estimation of antipyrine in plasma.

Authors:  L F Prescott; K K Adjepon-Yamoah; E Roberts
Journal:  J Pharm Pharmacol       Date:  1973-03       Impact factor: 3.765

10.  Cimetidine: interaction with oral anticoagulants in man.

Authors:  M J Serlin; R G Sibeon; S Mossman; A M Breckenridge; J R Williams; J L Atwood; J M Willoughby
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

  10 in total
  46 in total

1.  Drug interactions through binding to cytochrome p 450: the experience with h2-receptor blocking agents.

Authors:  U Klotz; I W Reimann
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

2.  An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin.

Authors:  L Purkins; S D Oliver; S A Willavize
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

Review 3.  Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A H Price; R N Brogden
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 4.  Haematological adverse effects of histamine H2-receptor antagonists.

Authors:  J P Aymard; B Aymard; P Netter; B Bannwarth; P Trechot; F Streiff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

Review 5.  Dosage regimen of cimetidine reviewed. Possible drug accumulation after multiple oral doses.

Authors:  J Prandota; I J Smith; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Cimetidine versus famotidine: the effect on the pharmacokinetics of theophylline in rats.

Authors:  P Mojaverian; M L Rocci; C L Saccar; P H Vlasses; R K Ferguson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Apr-Jun       Impact factor: 2.441

7.  Lack of effect of ranitidine on warfarin action.

Authors:  M J Serlin; R G Sibeon; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

Review 8.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

9.  Influence of cimetidine on steady state concentration and metabolite formation from antipyrine infused with a rectal osmotic mini pump.

Authors:  M W Teunissen; C H Kleinbloesem; L G de Leede; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

10.  Cimetidine-induced alterations in desipramine plasma concentrations.

Authors:  J D Amsterdam; D J Brunswick; L Potter; M J Kaplan
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.